Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against influenza

Influenza and Other Respiratory Viruses(2023)10.1111/irv.13112Source: DataRank Database

Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against influenza is a research paper published in Influenza and Other Respiratory Viruses (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.24)OA: goldTopics (38)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Cunjin Wu,Huifen Li ORCID,Harrison Powell ORCID,Allison Chen ORCID,Guodong Zhu ORCID

Live enrichment

PubMed:36875207 PMC:PMC9975791 OpenAlex:https://openalex.org/W4323066692

NIAID NIH HHS

Grant: U01 AI165826

NIAID NIH HHS

Grant: R01 AI108907

NIAID NIH HHS

Grant: T32 AI007417

Center for Innovative Medicine, Johns Hopkins University

Milstein Medical Asian American Partnership Foundation

FWCI

2.24

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/irv.13112

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/irv.13112

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.13112

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/irv.13112

journalhttps://doi.org/10.1111/irv.13112

Fields of Study

Influenza Virus Research Studiesinterferon and immune responsesHerbal Medicine Research StudiesAnimalsDogsHumansAntiviral AgentsInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusNeuraminidaseViral Replicase Complex ProteinsMadin Darby Canine Kidney CellsOrthomyxoviridae InfectionsGlucosides

MeSH Terms

Viral Replicase Complex ProteinsAnimalsAntiviral AgentsDogsGlucosidesHumansNeuraminidaseOrthomyxoviridae InfectionsInfluenza B virusInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeMadin Darby Canine Kidney Cells

Keywords

Mechanism (biology)VirologyInfluenza A virusMedicineVirusPhysicsInfluenzaphillyrinantiviral effectFs21Influenza Rna Polymerase Inhibition

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation

10.6084/m9.figshare.24558055.v1figshare

Additional file 1 of Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation

10.6084/m9.figshare.24558055figshare

Additional file 2 of Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation

10.6084/m9.figshare.24558235figshare

Additional file 2 of Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation

10.6084/m9.figshare.24558235.v1figshare